In a significant development for Pharma.Aero, Novartis, represented by Dr. Roland Yap, has been elected to the organization’s Board of Directors, bringing a wealth of experience and expertise to the table. The Board members, including Liew Zhong Yao from Changi Airport as Vice-Chair, Samuel Speltdoorn from Brussels Airport, Hugo Repolho from Guarulhos Airport, Bruno Guella from LACC, and Gergely Szorcsik from Zoetis, have all been reelected for a second mandate. Trevor Caswell, representing Edmonton Airport, will continue to serve as the Chair of Pharma.Aero.
Novartis joins Pharma.Aero Board of Directors; Board Members reelected with Trevor Caswell as Chair
I am humbled and deeply honored to be elected to the Board of Directors of Pharma.Aero. This presents an excellent opportunity to represent the pharmaceutical and life sciences community, engaging with key stakeholders to address business, logistics, government policies, and sustainability challenges. I am excited to collaborate with industry leaders on projects that will bring value to all segments for our key stakeholders and the industry as a whole.
Dr. Roland Yap, Global Head of Health Policy (Radioligand Therapy and Innovation/Pluvicto), Global Public Affairs, Novartis
Upon being re-elected as Chair of Pharma.Aero, I am immensely proud of the strides and growth we have achieved in recent years. Our focus on qualitative growth has enhanced project standards, delivering added value to our members and the industry. Moving forward, I am eager to build on this foundation, fostering innovation and collaboration in global pharmaceutical transportation. Together, we will embark on new initiatives to meet industry needs and enhance healthcare logistics efficiency on a global scale. I am honored to lead Pharma.Aero and work with an exceptional Board of Directors and back-office staff as we strive for collective achievements in the years ahead.